Cardio-Oncology

Explore how to mitigate the effects of cancer on the heart.

Science News

Speckle-Tracking Strain Echocardiography for the Assessment of Left Ventricular Structure and Function
Revisiting the Open Vein Hypothesis to Reduce the Postthrombotic Syndrome: Implications for Multidisciplinary Care and Research
Palliative Care and Advanced Cardiovascular Disease in Adults
Risk-Based Primary Prevention of Heart Failure
Cardiovascular Toxicity in Patients Treated for Childhood Cancer

Journals

Diagnostic Performance and Interpreter Experience of 1-Hour Versus 3-Hour 99mTc-HMDP Cardiac Amyloid Radionuclide Imaging: A Prospective, Blinded Comparison
Modeling Long-QT Syndrome Using Gene-Edited Miniature Pigs
Letter by Sun and Ren Regarding Article, “METTL4-Mediated Mitochondrial DNA N6-Methyldeoxyadenosine Promoting Macrophage Inflammation and Atherosclerosis”
Why We Must Rethink Kidney Transplantation as a Cardiovascular Risk–Reducing Intervention in Kidney Failure
Cardiovascular-Kidney Effects of Dapagliflozin in Patients at Cardiovascular Risk With or Without Type 2 Diabetes: Results of a Randomized, Double-Blind, Placebo-Controlled Trial
The CLCD Council supports AHA objectives in clinical cardiology, promotes excellent clinical care, and fosters professional development and education for clinical cardiologists. Through council-sponsored symposia, panels, and scientific conferences, members can access and interpret new developments in the field and promote clinical cardiology to professional and lay audiences.

The GPM Council seeks to advance discovery and translation of biological insights from genetics and omics technologies to improve cardiovascular and brain health through better risk prediction, treatment and prevention for patients. Our expertise spans genetics, genomics, genomic medicine, epigenetics, transcriptomics, metabolomics, proteomics, microbiome, bioinformatics, computational science, and population health.

CEO Nancy Brown on Cardio Oncology

CEO Nancy Brown explains why the AHA is funding a Strategically Focused Research Network on cardio-oncology with $15 million and, working with CancerLinQ LLC, making oncology datasets available on a version of the Precision Medicine Platform.

American Heart Association Professional Members

Enjoy instant benefits!

  • Free Online Access to AHA Scientific Journals
  • Affiliate with our 16 Scientific Councils
  • Discounts on Scientific Conference Registration and Online Courses

Learn more about Professional Membership